Technical feasibility study for an at-home multiplex lateral flow test for monitoring biomarkers in menstrual blood for polycystic ovary syndrome.
Technical feasibility study for an at-home multiplex lateral flow test for monitoring biomarkers in menstrual blood for polycystic ovary syndrome.
批准号:
10043120
负责人:
金额:
$6.37万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
Woost Ltd是一家新成立的有限元技术初创公司,致力于开发新技术,显著提高对从多囊卵巢综合征(PCOS)开始的妇科健康状况的认识和诊断,PCOS是一种卵巢功能障碍。我们致力于建立一个社区,在这个社区中,女性的健康关切被有效地瞄准,更重要的是被倾听。在目前的医疗生态系统中,出现任何症状的女性必须克服可获得性和可及性的限制,前往医生办公室接受医疗帮助。在参加完预约后,五分之四的女性觉得医护人员没有好好听取她们的意见,导致她们在漫长的诊断过程中经历了令人沮丧的经历。多囊卵巢综合征与危及生命的疾病(如糖尿病)的出现有直接关系,因此,早期诊断对妇女的生活质量极其重要。然而,疫情进一步限制了医疗保健的可及性,并加剧了人们对这些女性延误诊断的担忧。Woost的使命是取消这些限制,为女性提供控制自己健康之旅所需的支持。我们将妇女置于医疗保健需求的中心,直接向她们提供诊断工具,以了解她们的症状基础。女性可以加入我们的数字平台,订购我们的家庭检测试剂盒来检查月经血液,以便更早地诊断多囊卵巢综合征。能够在舒适的家中查看他们的结果,消除了以前经历的任何地点和时间的限制,有助于更早和更详细地诊断妇科疾病。通过提供远程分诊,我们正在消除临床医生执行常规分析测试的需要,因此我们现在可以增加临床医生用于患者参与和疾病治疗的时间。伍斯特的月经血检将简单易用,价格实惠,任何地方的任何女性都可以使用,以监测她们的妇科健康状况。
英文摘要
Woost Ltd is a new fem-tech start-up who are dedicated to the development of novel technologies to significantly improve the awareness and diagnosis of gynaecological health conditions starting with polycystic ovary syndrome (PCOS), an ovarian dysfunction. We are devoted to building a community, in which women's health concerns are effectively targeted and more importantly, being heard.In the current healthcare ecosystem women experiencing any symptoms have to overcome restrictions on availability and accessibility and travel to the doctor's office to receive medical help. After attending their appointments, 4 in 5 women felt they were not properly listened to by healthcare professionals leading to disheartening experiences women have been through from their long journey to diagnosis. PCOS has a direct relation to the emergence of life-threatening diseases (e.g. diabetes) and thus an earlier diagnosis is tremendously important for women's quality of life. And yet, the pandemic further limited the accessibility to healthcare and enhanced concerns around the resulting delayed diagnoses for these women.Woost's mission is to eliminate these restrictions and provide women the support they need to take control of their own health journey. We put women at the centre of their healthcare needs by directly offering them diagnostic tools to understand the basis of their symptoms. Women can join our digital platform and order our at-home test kits to examine menstrual blood for an earlier diagnosis of PCOS. Having access to their results from the comfort of their home eliminates any previously experienced location- and time-specific constraints and facilitates an earlier and more detailed diagnosis of gynaecological conditions. Providing remote triage, we are removing the need for clinicians to perform routine analytical testing and thus we are increasing the time clinicians can now spend on patient engagement and disease treatment. Woost's menstrual blood tests will be easy-to-use, affordable and accessible to be used by any woman anywhere to monitor their gynaecological well-being.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金